Menu
X

Treatment Details

Tirzepatide

Brand Name: Zepbound, Mounjaro
Drug Class: GIP/GLP-1 Agonist
FDA Category: Prescription Medication
Ratings
0 Comments
Views

n/a

Effectiveness

n/a

Side Effects

n/a

Cost

Overview

Explore the data

How it works:

Activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, increasing insulin secretion, decreasing glucagon secretion, increasing insulin sensitivity, and delaying gastric emptying.

Dosage Form: Tablet INJ (pen): 2.5mg per injection (INJ), 5 mg per INJ, 7.5mg per INJ, 10 mg per INJ, 12.5mg per INJ, 15 mg per INJ; INJ (vial): 2.5mg per 0.5 ml, 5mg per 0.5ml, 7.5 mg per 0.5 ml, 10 mg per 0.5ml, 2.5 mg per 0.5ml, 15mg per 0.5ml

Common Usage: Diabetes (type 2), Weight management, Obstructive sleep apnea (moderate-severe)

Precautions:

Pregnancy

Inadequate human data available; risk of teratogenicity and decreased fetal weight based on animal data

Lactation

No human data available, though risk of infant harm not expected based on drug properties; no human data available to assess effect on mild production

Warnings

Contraindicated in patients with personal history of medullary thyroid carcinoma or family history of multiple endocrine neoplasia syndrome type 2 (MEN 2).

© 2024 CompendiRx.com. All Rights Reserved. Information on Ratings and Reviews is reported by our members and is not medical advice.

Related Medicines

Write a Review

Subscribe
Notify of
guest
What symptom did you target?
Effectiveness rating
Side effect rating
Cost
0 Comments
Inline Feedbacks
View all comments

© 2024 CompendiRx.com. All Rights Reserved. Information on Ratings and Reviews is reported by our members and is not medical advice.

Submission Date: Dec 7, 2025, 02:31PM

Last Update Date: Dec 7, 2025, 02:31PM